UNIVERSAL-PEACE-FED
10.9.2020 11:43:11 CEST | Business Wire | Press release
In an attempt to spread hope and optimism during the coronavirus pandemic which has infected more than 27 million people and killed over 189,000 globally, UPF, an NGO in general consultative status with the Economic and Social Council of the United Nations will convene its first virtual International Leadership Conference (ILC) on Sept. 11-13, 2020.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200910005456/en/
The ILC will host concurrent webinars in three, time-zone friendly clusters: the Americas, Asia Pacific, and the combined continents of Europe, Africa, and the Middle East.
“This year has seen dramatic disruptions, not only due to the COVID-19 pandemic but in geopolitics, the world economy, the media, religion and all levels of society,” said Universal Peace Federation Chairman Dr. Thomas G. Walsh.
“When the world’s leaders and citizens gather and listen to each other,” he added, “it’s easy to envision how our friendships can grow, and how we can live as one global family.”
Former Secretary-General of the United Nations, Mr. Ban Ki-moon said at the recent virtual summit “Rally of Hope”, Aug. 9, 2020, he believed that “UPF will become a cornerstone to build lasting peace around the world.”
In addition to addressing major issues of the day, the conference will commemorate the 15-year anniversary of the Universal Peace Federation and the centenary of UPF’s Co-Founder, Rev. Dr. Sun Myung Moon (1920-2012).
Featured speakers in the Europe, Africa and Middle-East Peace-Dialogue will include former heads of state such as Goodluck Jonathan from Nigeria or H.E Marie-Louise Coleiro Preca from Malta, or Dr. Werner Fasslabend, former minister of defense, Austria, religious leaders with a large following such as Prophet Radebe from South Africa or Cheikh Soufi Bilal Diallo from Mali, and business leaders such as the philanthropist Joseph Busha from Zimbabwe.
The September 11-13 program will highlight the work of UPF’s seven Associations: International Summit Council for Peace (ISCP), International Association of Parliamentarians for Peace (IAPP), Interreligious Association for Peace and Development (IAPD), International Media Association for Peace (IMAP), International Association of Academicians for Peace (IAAP), International Association for Peace and Economic Development (IAED) and International Association of First Ladies for Peace (IAFLP).
Please register for the ILC sessions here: http://www.ilc-2020.org . You will then receive by email an invitation including all the links for each session as well as a brief description of each session. In addition to English, translations will be available in Arabic, French, Portuguese, Spanish and Russian. Attendance is free.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200910005456/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Secures €50M Financing to Accelerate Global Growth30.3.2026 08:00:00 CEST | Press release
€50 million financing package from funds and accounts managed by BlackRock will support IQM to scale operations, accelerate product development, and strengthen its market position. The facility will support acceleration of IQM’s technology roadmap, fuel R&D, support entry into additional markets, and advance IQM’s leadership in quantum computing as IQM prepares for public listing. IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), today announced it has secured a €50 millionfinancing package from funds and accounts managed by BlackRock. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329996942/en/ IQM Radiance quantum computer is located in IQM's showroom in Espoo, Finland. This facility will support acceleration of IQM’s technology roadmap, fuel R&D, support entry into additional markets, and advance IQM’s leadership in quantum computing. This
Bureau Veritas and Trade Technologies Join Forces to Streamline Global Trade Operations30.3.2026 07:45:00 CEST | Press release
Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), through its Swiss branch Government Services Division, is pleased to announce a strategic agreement with Trade Technologies, the leading provider of trade finance automation, connectivity and transaction management services. This collaboration is a significant step toward reducing the complexities of international trade operations, particularly in regions where regulatory and inspection controls remain stringent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329411683/en/ Addressing Critical Trade Finance Challenges The agreement comes at a pivotal time for global trade. Letters of Credit (LCs) continue to serve as essential instruments in international commerce, particularly across the Middle East and Africa, where counterparty risk, foreign exchange controls, sanctions exposure, and regulatory oversight face ongoing challenges. In
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 01:35:00 CEST | Press release
~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~ Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Cap
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom